Free equity investment tool of Japanese companies

Financial Indicator Details

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

Daito Pharmaceutical Co .

ZERIA PHARMACEUTICAL

参天製薬

MUTO SEIKO CO.

MATSUMOTO YUSHI-SEIYAKU

MITSUBISHI PLASTICS

JSP

Soken Chemical & Engineering

DAINICHISEIKA COLOR & CHEMICALS MFG.

TAIKO PHARMACEUTICAL

Sumitomo Seika Chemicals

EBARA-UDYLITE　

電気化学工業

タキロン

C.Uyemura

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

1/28 Retail Trade (CAWACHI:A etc...

1/27 Banks (The Awa Bank:BBB→A)

1/23 Chemicals (Milbon:AA→AAA)

1/21 Glass & Ceramics Products (..

1/21 Machinery (TSUDAKOMA:C)

1/21 Other Services (Netindex.:CC)

1/20 Other Products (Kurogane Kos..

1/20 Wholesale Trade (リーバイ・..

1/20 Other Services (川崎地質:BB→..

1/17 Chemicals (Kawaguchi Chemica..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

PIONEER

メルコホールディングス

Nissan Motor

Nittetsu Mining

日本アビオニクス

Financial Indicator Details: POLA ORBIS HOLDINGS (Annual )

Two or more periods are displayed by each of financial indicator collectively.Two or more companies can be compared and financial indicator data can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

*Free Download Financial Indicator data

Indicator Summary: POLA ORBIS HOLDINGS (Annual )

Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2010-12-31	2011-12-31	2012-12-31
Net profit margin (Industry Average)	4.28% (1.53%)	4.82% (-1.67%)	3.69% (3.05%)
C/F margin (Industry Average)	10.83% (7.04%)	8.64% (6.35%)	9.72% (8.25%)
ROA (Industry Average)	3.77% (2.07%)	4.16% (0.06%)	3.19% (2.71%)
ROE (Industry Average)	4.62% (2.96%)	5.11% (4.68%)	4.05% (4.57%)
Growth	2010-12-31	2011-12-31	2012-12-31
Equity growth (Industry Average)	- (2.61%)	2.58% (-0.40%)	4.99% (8.16%)
Sales growth (Industry Average)	- (-)	0.84% (1.07%)	8.53% (2.24%)
Net profit growth (Industry Average)	- (63.25%)	13.44% (3.89%)	-16.89% (90.38%)
Operating C/F growth (Industry Average)	- (35.09%)	-19.57% (-6.09%)	22.15% (138.39%)
Stability	2010-12-31	2011-12-31	2012-12-31
Capital adequacy (Industry Average)	81.53% (55.00%)	81.36% (53.59%)	78.84% (56.30%)
Liquidity ratio (Industry Average)	453.92% (237.55%)	467.01% (239.89%)	285.80% (236.21%)
C/F ratio current liabilities (Industry Average)	131.92% (434.79%)	165.18% (929.73%)	176.70% (573.30%)
Quick ratio (Industry Average)	229.52% (156.17%)	300.14% (160.84%)	145.51% (156.81%)
Turnover	2010-12-31	2011-12-31	2012-12-31
Receivables turnover (Industry Average)	43.16day (93.96day)	45.37day (97.92day)	45.77day (98.27day)
Inventory turnover (Industry Average)	33.88day (52.64day)	34.30day (56.59day)	34.86day (58.68day)
Payable turnover (Industry Average)	7.83day (49.52day)	6.33day (52.10day)	7.32day (51.12day)
Working capita turnover (Industry Average)	69.21day (97.08day)	73.34day (102.41day)	73.31day (105.83day)
Stock etc.	2010-12-31	2011-12-31	2012-12-31
Market Value growth (Industry Average)	- (1.49%)	23.58% (-3.85%)	19.08% (21.16%)
Dividend Yield (Industry Average)	1.06% (2.17%)	2.76% (2.45%)	1.93% (2.07%)
PER (Industry Average)	13.60% (16.22%)	14.82% (29.19%)	21.23% (16.58%)
PBR (Industry Average)	0.62% (1.04%)	0.75% (0.95%)	0.86% (1.08%)
PCFR (Industry Average)	5.38% (-2.43%)	8.27% (9.50%)	8.06% (7.56%)
PSR (Industry Average)	0.58% (1.10%)	0.71% (0.90%)	0.78% (1.01%)

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2010-12-31	2011-12-31	2012-12-31
Net profit margin (Industry Average)	43.66% (-5.37%)	36.77% (-10.69%)	45.12% (8.92%)
C/F margin (Industry Average)	- (0.82%)	- (-0.81%)	- (-39.63%)
ROA (Industry Average)	1.44% (1.42%)	1.12% (-0.27%)	1.51% (1.53%)
ROE (Industry Average)	1.90% (1.81%)	1.57% (3.42%)	2.21% (2.62%)
Growth	2010-12-31	2011-12-31	2012-12-31
Equity growth (Industry Average)	- (3.03%)	-1.34% (0.04%)	0.26% (3.91%)
Sales growth (Industry Average)	- (-)	-2.92% (0.75%)	15.13% (-1.74%)
Net profit growth (Industry Average)	- (43.48%)	-18.24% (-47.04%)	41.25% (62.14%)
Operating C/F growth (Industry Average)	- (77.44%)	- (-44.41%)	- (46.89%)
Stability	2010-12-31	2011-12-31	2012-12-31
Capital adequacy (Industry Average)	76.09% (57.17%)	71.62% (55.93%)	68.29% (57.57%)
Liquidity ratio (Industry Average)	150.59% (266.94%)	134.13% (314.47%)	- (233.84%)
C/F ratio current liabilities (Industry Average)	- (31.35%)	- (76.77%)	- (31.87%)
Quick ratio (Industry Average)	53.45% (174.83%)	84.88% (228.06%)	- (169.77%)
Turnover	2010-12-31	2011-12-31	2012-12-31
Receivables turnover (Industry Average)	- (95.88day)	- (98.58day)	- (67.18day)
Inventory turnover (Industry Average)	- (47.43day)	- (50.67day)	- (38.21day)
Payable turnover (Industry Average)	- (51.13day)	- (53.57day)	- (34.24day)
Working capita turnover (Industry Average)	- (92.19day)	- (95.69day)	- (71.15day)
Stock etc.	2010-12-31	2011-12-31	2012-12-31
Market Value growth (Industry Average)	- (3.11%)	23.58% (-3.30%)	19.08% (24.19%)
Dividend Yield (Industry Average)	- (0.10%)	- (0.16%)	- (0.15%)
PER (Industry Average)	41.37% (13.58%)	62.54% (22.26%)	52.72% (26.42%)
PBR (Industry Average)	0.78% (1.17%)	0.98% (1.08%)	1.17% (1.54%)
PCFR (Industry Average)	- (0.23%)	- (0.08%)	- (4.97%)
PSR (Industry Average)	18.06% (3.67%)	23.00% (4.37%)	23.79% (10.14%)

Financial Indicator Details: POLA ORBIS HOLDINGS

Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2010-12-31	2011-12-31	2012-12-31
Profitability
Net profit margin	4.28%	4.82%	3.69%
C/F margin	10.83%	8.64%	9.72%
ROA	3.77%	4.16%	3.19%
ROE	4.62%	5.11%	4.05%
Recurring margin	7.41%	7.99%	8.07%
EBIT margin	7.11%	6.47%	7.69%
EBITDA margin	10.14%	9.68%	11.26%
NOPAT margin	4.26%	3.88%	4.61%
Sales SG rates	20.16%	20.07%	20.42%
Sales SG&A rates	72.41%	72.20%	72.09%
Sales R&D expenses rates	-	-	-
Sales depreciation rates	3.03%	3.21%	3.57%
Capital expenditures net sales ratio	-2.47%	-1.45%	-3.72%
Indicator	2010-12-31	2011-12-31	2012-12-31
Growth
Growth rate of cash	-	46.14%	-55.50%
Equity growth	-	2.58%	4.99%
Total assets growth	-	2.79%	8.34%
Sales growth	-	0.84%	8.53%
Net profit growth	-	13.44%	-16.89%
Operating C/F growth	-	-19.57%	22.15%
Recurring profit growth	-	8.77%	9.62%
EBIT growth	-	-8.24%	29.04%
EBITDA growth	-	-3.75%	26.25%
NOPAT growth	-	-8.24%	29.04%
Operating expenses growth	-	-	-
Indicator	2010-12-31	2011-12-31	2012-12-31
Stability
Capital adequacy	81.53%	81.36%	78.84%
Liquidity ratio	453.92%	467.01%	285.80%
C/F ratio current liabilities	131.92%	165.18%	176.70%
Quick ratio	229.52%	300.14%	145.51%
Fixed ratio	33.73%	31.46%	33.60%
D/E ratio	1.14%	0.95%	1.05%
Loan to Value Ratio	0.93%	0.77%	0.82%
Business investment C/F ratio	-22.86%	-16.81%	-38.32%
Liabilities with interest growth	-	-14.43%	15.53%
Indicator	2010-12-31	2011-12-31	2012-12-31
Turnover
Cash turnover	76.59day	110.99day	45.50day
Receivables turnover	43.16day	45.37day	45.77day
Inventory turnover	33.88day	34.30day	34.86day
Fixed assets turnover	114.08day	108.23day	111.81day
Total asset turnover	414.73day	422.75day	422.04day
Payable turnover	7.83day	6.33day	7.32day
Capital turnover	22.08day	21.90day	20.17day
Equity turnover	338.16day	343.97day	332.75day
Working capita turnover	69.21day	73.34day	73.31day
Indicator	2010-12-31	2011-12-31	2012-12-31
Balance sheet
Cash etc.	¥ 34 B	¥ 50 B	¥ 22 B
Accounts receivable-trade	¥ 19 B	¥ 20 B	¥ 22 B
Other Current Assets	¥ 72 B	¥ 60 B	¥ 66 B
Current Assets	¥ 107 B	¥ 111 B	¥ 88 B
Tangible Assets	¥ 51 B	¥ 49 B	¥ 55 B
Intangible Assets	¥ 4 B	¥ 12 B	¥ 39 B
Investment etc.	¥ 24 B	¥ 20 B	¥ 25 B
Total Assets	¥ 187 B	¥ 193 B	¥ 209 B
Current Liabilities	¥ 23 B	¥ 23 B	¥ 31 B
Fixed Liabilities	¥ 11 B	¥ 12 B	¥ 13 B
Liabilities with interest	¥ 1 B	¥ 1 B	¥ 1 B
Net Assets	¥ 153 B	¥ 157 B	¥ 164 B
Capital stock	¥ 10 B	¥ 10 B	¥ 10 B
Capital surplus etc.	¥ 143 B	¥ 147 B	¥ 154 B
Liabilities and net assets	¥ 187 B	¥ 193 B	¥ 209 B
Indicator	2010-12-31	2011-12-31	2012-12-31
Income statement
Sales	¥ 165 B	¥ 166 B	¥ 180 B
Cost of Sales	¥ 33 B	¥ 33 B	¥ 36 B
Gross profit	¥ 131 B	¥ 133 B	¥ 143 B
Other income	¥ 2 B	¥ 1 B	¥ 1 B
SG&A	¥ 119 B	¥ 120 B	¥ 130 B
Other expenses	¥ 7 B	¥ 6 B	¥ 8 B
Net income	¥ 7 B	¥ 8 B	¥ 6 B
Operating income	¥ 12 B	¥ 12 B	¥ 13 B
Ordinary Income	¥ 12 B	¥ 13 B	¥ 14 B
EBITDA	¥ 16 B	¥ 16 B	¥ 20 B
Income before income taxes	¥ 12 B	¥ 11 B	¥ 14 B
Depreciation	¥ 5 B	¥ 5 B	¥ 6 B
R&D expenses	-	-	-
Income taxes	¥ 5 B	¥ 3 B	¥ 7 B
Indicator	2010-12-31	2011-12-31	2012-12-31
Cash flow statement
Operating CF	¥ 17 B	¥ 14 B	¥ 17 B
Investment CF	¥ -40 B	¥ -3 B	¥ -39 B
Financial CF	¥ -2 B	¥ -4 B	¥ -3 B
Foreign Exchange Effects	¥ -60 M	¥ -124 M	¥ 172 M
Net Change in Cash	¥ -25 B	¥ 6 B	¥ -25 B
Free CF	¥ -22 B	¥ 10 B	¥ -22 B
Capital expenditures	¥ -4 B	¥ -2 B	¥ -6 B
Cash dividends paid	¥ -1 B	¥ -3 B	¥ -2 B
Repayment loans	-	-	-
Indicator	2010-12-31	2011-12-31	2012-12-31
Shareowners' equity
Issuance of new shares	-	-	-
Dividends from surplus	¥ -1 B	¥ -3 B	¥ -2 B
Net income	¥ 7 B	¥ 8 B	¥ 6 B
Purchase of treasury stock	¥ 6 B	-	-
Other Change in Stockholders Equity	¥ -1 M	-	-
Other Change in Net Assets	¥ -621 M	¥ -769 M	¥ 3 B
Net Change in Net Assets	¥ 12 B	¥ 3 B	¥ 7 B

Financial Indicator Details: POLA ORBIS HOLDINGS

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2010-12-31	2011-12-31	2012-12-31
Profitability
Net profit margin	43.66%	36.77%	45.12%
C/F margin	-	-	-
ROA	1.44%	1.12%	1.51%
ROE	1.90%	1.57%	2.21%
Recurring margin	66.90%	66.11%	70.60%
EBIT margin	41.94%	40.23%	-
EBITDA margin	44.71%	43.12%	-
NOPAT margin	25.16%	24.13%	-
Sales SG rates	0.01%	0.05%	54.87%
Sales SG&A rates	41.71%	46.62%	-
Sales R&D expenses rates	-	-	-
Sales depreciation rates	2.77%	2.89%	-
Capital expenditures net sales ratio	-	-	-
Indicator	2010-12-31	2011-12-31	2012-12-31
Growth
Growth rate of cash	-	98.60%	-100.00%
Equity growth	-	-1.34%	0.26%
Total assets growth	-	4.80%	5.17%
Sales growth	-	-2.92%	15.13%
Net profit growth	-	-18.24%	41.25%
Operating C/F growth	-	-	-
Recurring profit growth	-	-4.06%	22.94%
EBIT growth	-	-6.88%	-100.00%
EBITDA growth	-	-6.37%	-100.00%
NOPAT growth	-	-6.88%	-100.00%
Operating expenses growth	-	-	-
Indicator	2010-12-31	2011-12-31	2012-12-31
Stability
Capital adequacy	76.09%	71.62%	68.29%
Liquidity ratio	150.59%	134.13%	-
C/F ratio current liabilities	-	-	-
Quick ratio	53.45%	84.88%	-
Fixed ratio	6.30%	6.38%	-
D/E ratio	1.22%	1.24%	-
Loan to Value Ratio	0.93%	0.88%	-
Business investment C/F ratio	-	-	-
Liabilities with interest growth	-	-	-100.00%
Indicator	2010-12-31	2011-12-31	2012-12-31
Turnover
Cash turnover	1,373.60day	2,810.21day	-
Receivables turnover	-	-	-
Inventory turnover	-	-	-
Fixed assets turnover	528.68day	543.76day	-
Total asset turnover	11,015.11day	11,892.37day	10,863.15day
Payable turnover	-	-	-
Capital turnover	684.03day	704.63day	-
Equity turnover	8,382.07day	8,518.45day	7,418.60day
Working capita turnover	-	-	-
Indicator	2010-12-31	2011-12-31	2012-12-31
Balance sheet
Cash etc.	¥ 20 B	¥ 39 B	-
Accounts receivable-trade	-	-	-
Other Current Assets	¥ 36 B	¥ 23 B	-
Current Assets	¥ 56 B	-	-
Tangible Assets	¥ 7 B	¥ 7 B	-
Intangible Assets	¥ 282 M	¥ 282 M	-
Investment etc.	¥ 96 B	¥ 97 B	¥ 177 B
Total Assets	¥ 161 B	¥ 168 B	¥ 177 B
Current Liabilities	¥ 37 B	¥ 46 B	¥ 56 B
Fixed Liabilities	¥ 924 M	¥ 898 M	-
Liabilities with interest	¥ 1 B	¥ 1 B	-
Net Assets	¥ 122 B	¥ 120 B	¥ 121 B
Capital stock	¥ 10 B	¥ 10 B	-
Capital surplus etc.	¥ 112 B	¥ 110 B	¥ 121 B
Liabilities and net assets	¥ 161 B	-	-
Indicator	2010-12-31	2011-12-31	2012-12-31
Income statement
Sales	¥ 5 B	¥ 5 B	¥ 5 B
Cost of Sales	¥ 1 M	¥ 3 M	¥ 3 B
Gross profit	¥ 5 B	¥ 5 B	¥ 2 B
Other income	¥ 660 M	¥ 815 M	-
SG&A	¥ 2 B	¥ 2 B	-
Other expenses	¥ 1 B	¥ 1 B	-
Net income	¥ 2 B	¥ 1 B	¥ 2 B
Operating income	¥ 3 B	¥ 2 B	¥ 3 B
Ordinary Income	¥ 3 B	¥ 3 B	¥ 4 B
EBITDA	¥ 2 B	¥ 2 B	-
Income before income taxes	¥ 2 B	-	-
Depreciation	¥ 148 M	¥ 150 M	-
R&D expenses	-	-	-
Income taxes	¥ 48 M	-	-
Indicator	2010-12-31	2011-12-31	2012-12-31
Cash flow statement
Operating CF	-	-	-
Investment CF	-	-	-
Financial CF	-	-	-
Foreign Exchange Effects	-	-	-
Net Change in Cash	-	-	-
Free CF	-	-	-
Capital expenditures	-	-	-
Cash dividends paid	-	-	-
Repayment loans	-	-	-
Indicator	2010-12-31	2011-12-31	2012-12-31
Shareowners' equity
Issuance of new shares	-	-	-
Dividends from surplus	¥ -1 B	-	-
Net income	¥ 2 B	-	-
Purchase of treasury stock	¥ 6 B	-	-
Other Change in Stockholders Equity	¥ -1 M	-	-
Other Change in Net Assets	¥ -57 M	-	-
Net Change in Net Assets	¥ 8 B	-	-

Free Download

*Free Download Financial Indicator dataMember limited service.

[Data] Net Profit Margin, Sales Growth, Equity Margin etc., 100 or more kinds of financial indicators. (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link

Related Information: POLA ORBIS HOLDINGS (Annual )

Statement Type

Annual : POLA ORBIS HOLDINGS

First quarter : POLA ORBIS HOLDINGS

Second quarter : POLA ORBIS HOLDINGS

Third quarter : POLA ORBIS HOLDINGS

Analysis Menu

Outline : POLA ORBIS HOLDINGS

Statement : POLA ORBIS HOLDINGS

Rating : POLA ORBIS HOLDINGS

Indicator : POLA ORBIS HOLDINGS

Download : POLA ORBIS HOLDINGS

Industry Comparison Ranking

Chemicals - EDIUNET Industry Rankings

Chemicals - EDIUNET Credit Rating

Chemicals - EDIUNET Industry Avg

Comparison with a neighboring company

Tokyo - EDIUNET Prefectures

Tokyo品川区 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/23	Milbon	AA→AAA	2013-12-20
1/17	Kawaguchi Chemical Indu..	BBB→BB	2013-11-30
1/17	SANKEI CHEMICAL	A	2013-11-30
1/15	HOKKO CHEMICAL INDUSTRY	BB→B	2013-11-30
1/15	Daito Pharmaceutical Co .	AA	2013-11-30 (Q2)
1/15	KAWAKAMI PAINT MFG.	B→BB	2013-11-30
1/15	旭化学工業	AA	2013-11-30 (Q1)
1/10	OSAKA ORGANIC CHEMICAL ..	BB→BBB	2013-11-30
1/10	HISAMITSU PHARMACEUTICAL	A	2013-11-30 (Q3)
1/10	AMS Life Science	BBB→BB	2013-11-30 (Q1)

EDIUNET Investment News (Chemicals)

1/23 Chemicals (Milbon:AA→AAA)

1/17 Chemicals (Kawaguchi Chemica..

1/15 Chemicals (HOKKO CHEMICAL IN..

1/10 Chemicals (OSAKA ORGANIC CHE..

1/9 Chemicals (SANKO GOSEI:A)

12/27 Chemicals (Niitaka:A)

12/18 Chemicals (KUMIAI CHEMICAL I..

12/12 Chemicals (IHARA CHEMICAL IN..

12/11 Chemicals (Konoshima Chemica..

12/10 Chemicals (NATOCO:AA)

Company Information

Ticker	Market	Industry	Month	report	Rating
POLA ORBIS HOLDINGS	4927	TSE 1st	Chemicals	12	Annual	AA

Related Company

AIR WATER (Sales ¥ 540 B)

SANYO CHEMICAL INDUSTRIES (Sales ¥ 142 B)

日本曹達 (Sales ¥ 127 B)

参天製薬 (Sales ¥ 119 B)

KOSE (Sales ¥ 170 B)

KAKEN PHARMACEUTICAL (Sales ¥ 87 B)

Sumitomo Seika Chemicals (Sales ¥ 70 B)

電気化学工業 (Sales ¥ 341 B)

JSP (Sales ¥ 96 B)

MUTO SEIKO CO. (Sales ¥ 24 B)

Soken Chemical & Engineering (Sales ¥ 26 B)

KUREHA (Sales ¥ 130 B)

SANKO GOSEI (Sales ¥ 43 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .